Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Olfson

Showing results (91-100 of 683) with videos related to

Pageof 69
Sort By:
JAMA Psychiatry|September 19, 2019
Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed WarningVictoria Shu Zhang, Mark Olfson, Marissa King
The American Journal of Psychiatry|July 30, 2011
National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disordersJonathan S Comer, Ramin Mojtabai, Mark Olfson
JAMA Psychiatry|October 19, 2022
Implications of Telepsychiatry for Cost, Quality, and Equity of Mental Health CareCarlos Blanco, Melanie M Wall, Mark Olfson
Annals of Internal Medicine|February 19, 2024
Fatal Drug Overdose Risks of Health Care Workers in the United StatesMark Olfson, Melanie M Wall, Carlos Blanco
American Journal of Preventive Medicine|November 23, 2019
Prescription Benzodiazepine Use in Privately Insured U.S. Children and AdolescentsGreta A Bushnell, Stephen Crystal, Mark Olfson
JAMA|October 3, 2013
Investing in evidence-based care for the severely mentally illMark Olfson, Harold A Pincus, Herbert Pardes
The Journal of ECT|June 6, 2007
Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settingsHarold A Sackeim, Joan Prudic, Mark Olfson
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|July 15, 2024
Trends in mortality after emergency department presentation for suicidal behaviour in CaliforniaSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
JAMA Internal Medicine|August 30, 2016
Treatment of Adult Depression in the United StatesMark Olfson, Carlos Blanco, Steven C Marcus
Journal of General Internal Medicine|December 1, 2025
Work Disability and Fatal Opioid Overdose Risk in the United States: A Cohort StudyMark Olfson, Candace M Cosgrove, Carlos Blanco
Pageof 69

Showing results (91-100 of 683) with videos related to

Sort By:
Pageof 69
JAMA Psychiatry|September 19, 2019
Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed WarningVictoria Shu Zhang, Mark Olfson, Marissa King
The American Journal of Psychiatry|July 30, 2011
National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disordersJonathan S Comer, Ramin Mojtabai, Mark Olfson
JAMA Psychiatry|October 19, 2022
Implications of Telepsychiatry for Cost, Quality, and Equity of Mental Health CareCarlos Blanco, Melanie M Wall, Mark Olfson
Annals of Internal Medicine|February 19, 2024
Fatal Drug Overdose Risks of Health Care Workers in the United StatesMark Olfson, Melanie M Wall, Carlos Blanco
American Journal of Preventive Medicine|November 23, 2019
Prescription Benzodiazepine Use in Privately Insured U.S. Children and AdolescentsGreta A Bushnell, Stephen Crystal, Mark Olfson
JAMA|October 3, 2013
Investing in evidence-based care for the severely mentally illMark Olfson, Harold A Pincus, Herbert Pardes
The Journal of ECT|June 6, 2007
Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settingsHarold A Sackeim, Joan Prudic, Mark Olfson
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|July 15, 2024
Trends in mortality after emergency department presentation for suicidal behaviour in CaliforniaSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
JAMA Internal Medicine|August 30, 2016
Treatment of Adult Depression in the United StatesMark Olfson, Carlos Blanco, Steven C Marcus
Journal of General Internal Medicine|December 1, 2025
Work Disability and Fatal Opioid Overdose Risk in the United States: A Cohort StudyMark Olfson, Candace M Cosgrove, Carlos Blanco
Pageof 69